Global Head and Neck Cancer Therapeutics Market Size study, by Drug Class (Chemotherapy, Immunotherapy, and Targeted Therapy) and Sales Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Stores) and Regional Forecasts 2021-2027

BIZ4599851
200 Pages
July 2021
Pharmaceuticals

Download Sample Get Discount

Global Head and Neck Cancer Therapeutics Market is valued approximately USD 1.07 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 9.4% over the forecast period 2021-2027. Head and neck cancers are caused by malignant tumors that grow around the throat, nose, sinuses, salivary glands and mouth. Increase in occurrence of head & neck cancer across the world, rising awareness and demand for therapy to cure head and neck cancer, and growth in research activities are driving the Head and Neck Cancer Therapeutics market. The major risk factors for cancers of the head and neck are alcohol and tobacco. All tobacco products, including cigarettes and smokeless tobacco are linked to head and neck cancer. Drinking alcohol, such as beer, wine, or liquor, also raises the risk of getting cancers of the mouth, throat, and voice box. According to WHO’s Global Health Observatory, the total per capita alcohol consumption in India is expected to increase to 7.9 liters in 2025 from current 6.6% liters 2020. Similarly, the figure for United States is 10.3L from 10.1 L, 11.5L to 11.8L for UK and 8.1L from 7.5 for China in period 2020-2025. The increase in the alcohol consumption indicates the increase in consequent diseases, including cancers. Therapies to the head and neck may cause redness or skin irritation, tooth decay, speech problems and hearing loss. This issue may act as a restraint for its growth. However, increasing efforts from government and private entities in research and development of cancer therapies acts as an opportunity for Head and Neck Cancer Therapeutics Market in subsequent decade.

Key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World are analysed to provide a holistic picture of Head and Neck Cancer Therapeutics Market. Due to higher investment in research activities in cancer treatment as well as higher per capita income, North America has emerged as a significant region across the world in terms of market share. Whereas, Asia-Pacific is expected to exhibit the highest growth rate for the forecast period 2021-2027 owing to the growing population with affinity for alcoholic beverages and tobacco. Rising disposable income will also boost growth in this region.

Major market player included in this report are:

AstraZeneca Plc.

Bristol-Myers Squibb Company

Eli Lilly and Company

F. Hoffmann-La Roche Ltd. (Genentech, Inc.,)

Fresenius Medical Care AG & Co. KGaA

Merck & Co., Inc.

Pfizer Inc.

Sanofi

Sun Pharmaceutical Industries Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

Chemotherapy

Immunotherapy

Targeted Therapy

By Sales Channel:

Hospital pharmacy

Online providers

Drug stores & retail pharmacies

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027

Target Audience of the Global Head and Neck Cancer Therapeutics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Head and Neck Cancer Therapeutics Market, by Drug Class, 2019-2027 (USD Billion)

1.2.2. Head and Neck Cancer Therapeutics Market, by Sales Channel, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Head and Neck Cancer Therapeutics Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Head and Neck Cancer Therapeutics Market Dynamics

3.1. Head and Neck Cancer Therapeutics Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Increasing incidences of head and neck cancer

3.1.1.2. Growing population consuming alcohol and tobacco

3.1.2. Market Challenges

3.1.2.1. Side effects on skin and teeth due to radiation therapy

3.1.3. Market Opportunities

3.1.3.1. Increasing research and development to cure cancer

Chapter 4. Global Head and Neck Cancer Therapeutics Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Head and Neck Cancer Therapeutics Market, by Drug Class

5.1. Market Snapshot

5.2. Global Head and Neck Cancer Therapeutics Market by Drug Class, Performance - Potential Analysis

5.3. Global Head and Neck Cancer Therapeutics Market Estimates & Forecasts by Drug Class 2018-2027 (USD Billion)

5.4. Head and Neck Cancer Therapeutics Market, Sub Segment Analysis

5.4.1. Chemotherapy

5.4.2. Immunotherapy

5.4.3. Targeted Therapy

Chapter 6. Global Head and Neck Cancer Therapeutics Market, by Sales Channel

6.1. Market Snapshot

6.2. Global Head and Neck Cancer Therapeutics Market by Sales Channel, Performance - Potential Analysis

6.3. Global Head and Neck Cancer Therapeutics Market Estimates & Forecasts by Sales Channel 2018-2027 (USD Billion)

6.4. Head and Neck Cancer Therapeutics Market, Sub Segment Analysis

6.4.1. Hospital pharmacy

6.4.2. Online providers

6.4.3. Drug stores & retail pharmacies

Chapter 7. Global Head and Neck Cancer Therapeutics Market, Regional Analysis

7.1. Head and Neck Cancer Therapeutics Market, Regional Market Snapshot

7.2. North America Head and Neck Cancer Therapeutics Market

7.2.1. U.S. Head and Neck Cancer Therapeutics Market

7.2.1.1. Drug Class breakdown estimates & forecasts, 2018-2027

7.2.1.2. Sales Channel breakdown estimates & forecasts, 2018-2027

7.2.2. Canada Head and Neck Cancer Therapeutics Market

7.3. Europe Head and Neck Cancer Therapeutics Market Snapshot

7.3.1. U.K. Head and Neck Cancer Therapeutics Market

7.3.2. Germany Head and Neck Cancer Therapeutics Market

7.3.3. France Head and Neck Cancer Therapeutics Market

7.3.4. Spain Head and Neck Cancer Therapeutics Market

7.3.5. Italy Head and Neck Cancer Therapeutics Market

7.3.6. Rest of Europe Head and Neck Cancer Therapeutics Market

7.4. Asia-Pacific Head and Neck Cancer Therapeutics Market Snapshot

7.4.1. China Head and Neck Cancer Therapeutics Market

7.4.2. India Head and Neck Cancer Therapeutics Market

7.4.3. Japan Head and Neck Cancer Therapeutics Market

7.4.4. Australia Head and Neck Cancer Therapeutics Market

7.4.5. South Korea Head and Neck Cancer Therapeutics Market

7.4.6. Rest of Asia Pacific Head and Neck Cancer Therapeutics Market

7.5. Latin America Head and Neck Cancer Therapeutics Market Snapshot

7.5.1. Brazil Head and Neck Cancer Therapeutics Market

7.5.2. Mexico Head and Neck Cancer Therapeutics Market

7.6. Rest of The World Head and Neck Cancer Therapeutics Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies

8.2. Company Profiles

8.3. AstraZeneca Plc.

8.3.1.1. Key Information

8.3.1.2. Overview

8.3.1.3. Financial (Subject to Data Availability)

8.3.1.4. Product Summary

8.3.1.5. Recent Developments

8.3.2. Bristol-Myers Squibb Company

8.3.3. Eli Lilly and Company

8.3.4. F. Hoffmann-La Roche Ltd. (Genentech, Inc.,)

8.3.5. Fresenius Medical Care AG & Co. KGaA

8.3.6. Merck & Co., Inc.

8.3.7. Pfizer Inc.

8.3.8. Sanofis

8.3.9. Sun Pharmaceutical Industries Ltd.

8.3.10. Teva Pharmaceutical Industries Limited

Chapter 9. Research Process

9.1. Research Process

9.1.1. Data Mining

9.1.2. Analysis

9.1.3. Market Estimation

9.1.4. Validation

9.1.5. Publishing

9.2. Research Attributes

9.3. Research Assumption

List of Tables

TABLE 1. Global Head and Neck Cancer Therapeutics Market, report scope

TABLE 2. Global Head and Neck Cancer Therapeutics Market estimates & forecasts by region 2018-2027 (USD Billion)

TABLE 3. Global Head and Neck Cancer Therapeutics Market estimates & forecasts by Drug Class 2018-2027 (USD Billion)

TABLE 4. Global Head and Neck Cancer Therapeutics Market estimates & forecasts by Sales Channel 2018-2027 (USD Billion)

TABLE 5. Global Head and Neck Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 6. Global Head and Neck Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 7. Global Head and Neck Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 8. Global Head and Neck Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Head and Neck Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Head and Neck Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Head and Neck Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Head and Neck Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Head and Neck Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Head and Neck Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. U.S. Head and Neck Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. U.S. Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 17. U.S. Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 18. Canada Head and Neck Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 19. Canada Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 20. Canada Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 21. UK Head and Neck Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 22. UK Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 23. UK Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 24. Germany Head and Neck Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 25. Germany Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 26. Germany Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 27. RoE Head and Neck Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 28. RoE Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 29. RoE Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 30. China Head and Neck Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 31. China Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 32. China Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 33. India Head and Neck Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 34. India Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 35. India Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 36. Japan Head and Neck Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 37. Japan Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 38. Japan Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 39. RoAPAC Head and Neck Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 40. RoAPAC Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 41. RoAPAC Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 42. Brazil Head and Neck Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 43. Brazil Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 44. Brazil Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 45. Mexico Head and Neck Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 46. Mexico Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 47. Mexico Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 48. RoLA Head and Neck Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 49. RoLA Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 50. RoLA Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 51. Row Head and Neck Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 52. Row Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 53. Row Head and Neck Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 54. List of secondary sources, used in the study of global Head and Neck Cancer Therapeutics Market

TABLE 55. List of primary sources, used in the study of global Head and Neck Cancer Therapeutics Market

TABLE 56. Years considered for the study

TABLE 57. Exchange rates considered

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Global Head and Neck Cancer Therapeutics Market Size study, by Drug Class (Chemotherapy, Immunotherapy, and Targeted Therapy) and Sales Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Stores) and Regional Forecasts 2021-2027

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara